Dr. Corey Casper, M.D., M.P.H.

President and Chief Executive Officer

As AAHI’s President and CEO, Dr. Casper oversees a scientific portfolio of vaccines, therapeutics, and diagnostics that provide comprehensive solutions to global health problems. He is also responsible for the overall operations at AAHI, executing AAHI’s strategy, assuring adequate resources to achieve AAHI’s important mission, and representing AAHI to local, national and international stakeholders.

Dr. Casper is a medical doctor with over 20 years of experience conducting translational and clinical research in cancer and infectious disease. He has authored more than 130 peer-reviewed scientific publications, served as the Principal Investigator for many large projects funded by the National Institutes of Health, the Department of Defense, the Doris Duke Charitable Foundation and others. His research has led to the licensure of immunotherapies, the advancement of vaccines through late stage clinical trials, the development and deployment of new diagnostic assays, and the detailed characterization of the molecular underpinnings of cancers and infectious diseases in Sub-Saharan Africa, and has contributed more than 125 peer-reviewed papers to the medical literature; he also serves as an inventor on several patents.  Dr. Casper founded the first Global Oncology Program at a US designated comprehensive cancer center, and opened one of the first comprehensive cancer centers in sub-Saharan Africa – the Uganda Cancer Institute (UCI)/Hutchinson Center Cancer Alliance. This facility opened in 2015 and continues to serve as a leading center for cancer care, research, and medical education in East Africa.

In addition to his activities at AAHI, Dr. Casper remains a committed educator and is a Clinical Professor of Medicine and Global Health at the University of Washington, where he is also the Associate Director of the Centers for AIDS Research. He is an Affiliate Professor at the Fred Hutch Cancer Center, where he cares for patients with cancer and infectious diseases.


B.A., Biology, Wesleyan University, 1992
M.D., Medicine, Cornell University Medical College, 1997
Resident, Internal Medicine, University of California – San Francisco, 2000
M.P.H., Epidemiology, University of Washington, 2022
Senior Fellow, Infectious Disease, University of Washington, 2003

Recent Grants and Contracts

Principal investigator of an NIH funded project to develop RNA vaccines against Zika Virus and Yellow Fever (Contract No. 75N93019C00059).

Principal Investigator of a DoD-funded project to develop a nasal spray protective against multiple pandemic respiratory viral infections, based on AAHI’s adjuvant formulation technology (Contract No. HQ0845-23-9-0004).

Co-Principal Investigator of an NIH-funded project developing a live-attenuated vaccine against Chikungunya.